These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12424752)

  • 1. Recent development in the design of sialyltransferase inhibitors.
    Wang X; Zhang LH; Ye XS
    Med Res Rev; 2003 Jan; 23(1):32-47. PubMed ID: 12424752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialyltransferase inhibition and recent advances.
    Wang L; Liu Y; Wu L; Sun XL
    Biochim Biophys Acta; 2016 Jan; 1864(1):143-53. PubMed ID: 26192491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of flavonoids as sialyltransferase inhibitors.
    Hidari KI; Oyama K; Ito G; Nakayama M; Inai M; Goto S; Kanai Y; Watanabe K; Yoshida K; Furuta T; Kan T; Suzuki T
    Biochem Biophys Res Commun; 2009 May; 382(3):609-13. PubMed ID: 19303395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of bisubstrate and donor analogues of sialyltransferase and their inhibitory activities.
    Izumi M; Wada K; Yuasa H; Hashimoto H
    J Org Chem; 2005 Oct; 70(22):8817-24. PubMed ID: 16238314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stachybotrydial, a potent inhibitor of fucosyltransferase and sialyltransferase.
    Lin TW; Chang WW; Chen CC; Tsai YC
    Biochem Biophys Res Commun; 2005 Jun; 331(4):953-7. PubMed ID: 15882970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithocholic acid analogues, new and potent alpha-2,3-sialyltransferase inhibitors.
    Chang KH; Lee L; Chen J; Li WS
    Chem Commun (Camb); 2006 Feb; (6):629-31. PubMed ID: 16446832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential sialyltransferase inhibitors based on neuraminyl substitution by hetaryl rings.
    Mathew B; Schmidt RR
    Carbohydr Res; 2007 Feb; 342(3-4):558-66. PubMed ID: 16989791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic syntheses and inhibitory activities of bisubstrate-type inhibitors of sialyltransferases.
    Hinou H; Sun XL; Ito Y
    J Org Chem; 2003 Jul; 68(14):5602-13. PubMed ID: 12839452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly Substituted Cyclopentane-CMP Conjugates as Potent Sialyltransferase Inhibitors.
    Li W; Niu Y; Xiong DC; Cao X; Ye XS
    J Med Chem; 2015 Oct; 58(20):7972-90. PubMed ID: 26406919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of phosphoramidate amino acid-based inhibitors of sialyltransferases.
    Whalen LJ; McEvoy KA; Halcomb RL
    Bioorg Med Chem Lett; 2003 Jan; 13(2):301-4. PubMed ID: 12482445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric synthesis and reactivity of potent sialyltransferase inhibitors based on transition-state analogues: supplementary data.
    Skropeta D; Schwörer R; Haag T; Schmidt RR
    Glycoconj J; 2004; 21(5):221-5. PubMed ID: 15486454
    [No Abstract]   [Full Text] [Related]  

  • 12. Advancement of Sialyltransferase Inhibitors: Therapeutic Challenges and Opportunities.
    Szabo R; Skropeta D
    Med Res Rev; 2017 Mar; 37(2):219-270. PubMed ID: 27678392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sialyltransferase inhibitors: consideration of molecular shape and charge/hydrophobic interactions.
    Kumar R; Nasi R; Bhasin M; Huan Khieu N; Hsieh M; Gilbert M; Jarrell H; Zou W; Jennings HJ
    Carbohydr Res; 2013 Aug; 378():45-55. PubMed ID: 23374752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid regulation of terminal protein glycosyltransferase genes: molecular and functional homologies within sialyltransferase and fucosyltransferase families.
    Medvedova L; Knopp J; Farkas R
    Endocr Regul; 2003 Dec; 37(4):203-10. PubMed ID: 15106817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of sialyltransferases: potential roles in tumor growth and metastasis.
    Drinnan NB; Halliday J; Ramsdale T
    Mini Rev Med Chem; 2003 Sep; 3(6):501-17. PubMed ID: 12871154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural analysis of the sialyltransferase CstII from Campylobacter jejuni in complex with a substrate analog.
    Chiu CP; Watts AG; Lairson LL; Gilbert M; Lim D; Wakarchuk WW; Withers SG; Strynadka NC
    Nat Struct Mol Biol; 2004 Feb; 11(2):163-70. PubMed ID: 14730352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyoxometalates as effective inhibitors for sialyl- and sulfotransferases.
    Seko A; Yamase T; Yamashita K
    J Inorg Biochem; 2009 Jul; 103(7):1061-6. PubMed ID: 19508952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and evaluation of carbamate-linked uridyl-based inhibitors of human ST6Gal I.
    Montgomery AP; Dobie C; Szabo R; Hallam L; Ranson M; Yu H; Skropeta D
    Bioorg Med Chem; 2020 Jul; 28(14):115561. PubMed ID: 32616185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetric synthesis and affinity of potent sialyltransferase inhibitors based on transition-state analogues.
    Skropeta D; Schwörer R; Haag T; Schmidt RR
    Glycoconj J; 2004; 21(5):205-19. PubMed ID: 15486453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic study of 3-fluorinated sialic acid derivatives.
    Suzuki K; Daikoku S; Son SH; Ito Y; Kanie O
    Carbohydr Res; 2015 Apr; 406():1-9. PubMed ID: 25658060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.